Email this article 
Post a Comment NON-ALCOHOLIC FATTY LIVER DISEASE AS A NEW COMPONENT OF THE METABOLIC SYNDROME IN THE LIGHT OF MODERN METHODS OF DIAGNOSIS
- Authors: Denisov NV1, Grinevich VB1, Chernetcova EV1, Kornouchova LA2, Kravchuk UA1, Partsernyak SA3, Mironenko AN3
-
Affiliations:
- Military Medical Academy named after Kirov
- Northwest Medical Center
- City hospital №15
- Issue: Vol 9, No 1 (2017)
- Pages: 34-41
- Section: Reviews
- URL: https://journals.rcsi.science/vszgmu/article/view/8538
- DOI: https://doi.org/10.17816/mechnikov20179134-41
- ID: 8538
Cite item
Full Text
Abstract
The aim of the research was to study the biochemical model of morphological changes in the liver of patients with different forms of non-alcoholic fatty liver disease NAFLd, overweight and abdominal obesity (AO). Morphological changes in liver tissue were determined by non-invasive method Ste- atoskreen . The study evaluated the relationship between the cytolytic syndrome, forms of NAFLd and various manifestations of metabolic syndrome (MS). According to the survey, morphologically NAFLd was confirmed in 98% of patients using non-invasive diagnostic test Steatoskreen . The progression of different forms of NAFLd was significantly correlated with various metabolic disorders (dyslipidemia, impaired glucose metabolism, insulin resistance, obese) increases with the progression of NAFLd.
Full Text
##article.viewOnOriginalSite##About the authors
N V Denisov
Military Medical Academy named after Kirov
V B Grinevich
Military Medical Academy named after Kirov
E V Chernetcova
Military Medical Academy named after Kirov
L A Kornouchova
Northwest Medical Center
U A Kravchuk
Military Medical Academy named after Kirov
S A Partsernyak
City hospital №15
A N Mironenko
City hospital №15
References
- Ивашкин В.Т., Драпкина О.М., Шульпекова Ю.О. Диагностика и лечение неалкогольной жировой болезни печени. Методические рекомендации. М.:ООО «Издательский дом МВести», 2014.
- Никитин И.Г. Скрининговая программа по выявлению распространенности неалкогольной жировой болезни печени и определению факторов риска развития заболевания. Российские Медицинские Вести 2015; XV(1):41-6.
- Мязин Р.Г. Неалкогольная жировая болезнь печени: эволюция представлений, патогенетические акценты, подходы к терапии. Сonsilium medicum. 2015.
- Чернецова Е.В, Денисов Н.Л. Окружность талии и индекс массы тела у пациентов с абдоминальным ожирением и различными стадиями фибротических изменений в печеночной ткани при НАЖБП, определяемых с помощью неинвазивных методов диагностики - Стеатоскрина. Рос журн гастроэнт гепатол колопроктол 2016; 26(5, Приложение 48):69.
- Чернецова Е.В, Денисов Н.Л. Оценка взаимосвязи выраженности изменений в печени - стеатоза, фиброза, с метаболическими параметрами (общего холестерина, триглицеридов) у пациентов с абдоминальным ожирением и с различными формами НАЖБП. Рос журн гастроэнт гепатол колопроктол 2016; 26(5, Приложение 48):69.
- Чернецова Е.В, Денисов Н.Л. Изучение зависимости уровней маркеров воспалительнонекротических изменений в печени и прогрессированием стадий НАЖБП у пациентов с абдоминальным ожирением с помощью неинвазивных методов диагностики - Стеатоскрина. Рос журн гастроэнт гепатол колопроктол 2016; 26(5, Приложение48):69.
- Pais R, Rusu E, Zilisteanu D, Circiumaru A, Micu L, Voiculescu M, Poynard T, Ratziu V. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C. World J Gastroenterol. 2014; 40(9):108193.
- Shukla A., Kapileswar S., Gogtay N., Joshi A., Dhore P., Shah C., Abraham P., Bhatia S. Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals. Сlinbiochem. 2015; 48 (1011):652.
- Pais R., Rusu E., Zilisteanu D., Circiumaru A., Micu L., Voiculescu M., Poynard T., Ratziu V. Prognostic value of liver fibrosis and steatosis biomarkers in type2 diabetes and dyslipidaemia. World J Gastroenterol. 2014; 40(9):108193.
- Grattagliano I., Ubaldi E., Napoli L., Marulli C.F., Nebiacolombo C., Cottone C., Portincasa P. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. Annals of Hepatology. 2013; 12(1): 7077.
- Sayiner M., Koenig A., Henry L., Younossi Z.M. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clin Liver Dis. 2016 May; 20(2):20514.
- Sebastiani G., Alshaalan R., Wong P., Rubino M., Salman A., Metrakos P., Deschenes M., Ghali P. Cardiovascular risk across the histological spectrum and the clinical manifestations of nonalcoholic fatty liver disease: World J Gastroenterol. 2015; 21(22): 6820-6834.
- Kanwar P., Kowdley K.V. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis. Clin Liver Dis. 2016; 20(2):22543.
- Ikura Y. Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. World J Hepatol. 2014; 12(6):894-900.
- Kanwar P., Kowdley K.V. The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatit Hepatology. 2015;20(2):20514.
- Athyros V.G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., Mikhailidis D.P. Lowfasting triglyceride levels are associated with noninvasive markers of advanced liver fibrosis among adults in the United States. Aliment Pharmacol Ther. 2015; 42(1):10616.
- Golabi P., Sayiner M., Fazel Y., Koenig A., Henry L., Younossi Z.M. Simple biochemical parameters and a novel score correlate with absence of fibrosis in patients with nonalcoholic fatty liver disease. Indian J Gastroenterol. 2015; 34(4):2815.
- Kleiner D.E,.Makhlouf H.R. Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children. Clin Liver Dis. 2016; 20(2):293312.
Supplementary files
